Positive booster data for Sanofi/GSK COVID-19 vaccine
Preliminary results from the VAT0002 clinical trial for the vaccine as a booster shot showed neutralizing antibodies increased 9- to 43-fold, regardless of the primary vaccine received or the age of the individual (the vaccine was tested as a booster after AstraZeneca, J&J, Pfizer and Moderna vaccines).
www.biopharma-reporter.com
